{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:42:26Z","timestamp":1791495746007,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.jaci.2010.11.048","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T07:06:33Z","timestamp":1298703993000},"page":"S74-S81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"special_numbering":"S","title":["Immune pathomechanism of drug hypersensitivity reactions"],"prefix":"10.1016","volume":"127","author":[{"given":"Werner J.","family":"Pichler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Naisbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Kevin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2010.11.048_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2217\/pgs.10.12","article-title":"Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future","volume":"11","author":"Alfirevic","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaci.2010.11.048_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-139-8-200310210-00012","article-title":"Delayed drug hypersensitivity reactions","volume":"139","author":"Pichler","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2010.11.048_bib3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2165\/00002018-200023060-00002","article-title":"Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment","volume":"23","author":"Naisbitt","year":"2000","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaci.2010.11.048_bib4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1084\/jem.61.5.643","article-title":"Studies on the sensitization of animals with simple chemical compounds","volume":"61","author":"Landsteiner","year":"1935","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2010.11.048_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.114.6.875","article-title":"Studies on the mechanism of the formation of the penicillin antigen","volume":"114","author":"Levine","year":"1961","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2010.11.048_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000230197","article-title":"Minor haptenic determinant-specific reagins of penicillin hypersensitivity in man","volume":"35","author":"Levine","year":"1969","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib7","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/206362a0","article-title":"Penicillin allergy: the formation of the penicilloyl determinant","volume":"206","author":"Batchelor","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2010.11.048_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/prca.200800222","article-title":"Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo","volume":"3","author":"Jenkins","year":"2009","journal-title":"Proteomics Clin Applications"},{"key":"10.1016\/j.jaci.2010.11.048_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.1998.00122.x","article-title":"Molecular features of penicillin allergy","volume":"110","author":"Weltzien","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.11.048_bib10","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.155.5.2670","article-title":"Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals","volume":"155","author":"Brander","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2009.05.001","article-title":"Role of protein haptenation in triggering maturation events in the dendritic cell surrogate cell line THP-1","volume":"238","author":"Megherbi","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jaci.2010.11.048_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.0022-202X.2005.23624.x","article-title":"Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells","volume":"124","author":"Mizuashi","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.11.048_bib13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2010.11.048_bib14","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2010.11.048_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ACI.0b013e3283088cf9","article-title":"From innate to adaptive immune responses in contact hypersensitivity","volume":"8","author":"Martin","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib17","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jaci.2006.07.013","article-title":"Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams","volume":"118","author":"Rodriguez-Pena","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib18","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.4049\/jimmunol.178.9.5533","article-title":"Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling","volume":"178","author":"Sanderson","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib19","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3280119579","article-title":"Immune responses to abacavir in antigen-presenting cells from hypersensitive patients","volume":"21","author":"Martin","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jaci.2010.11.048_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/03602530903401658","article-title":"Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective","volume":"42","author":"Tang","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jaci.2010.11.048_bib21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/03602530600959466","article-title":"Addressing metabolic activation as an integral component of drug design","volume":"38","author":"Doss","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.jaci.2010.11.048_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","article-title":"Sulfamethoxazole is metabolized to the hydroxylamine in humans","volume":"51","author":"Cribb","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaci.2010.11.048_bib23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0960-894X(96)00260-0","article-title":"Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles\u2014implications for immune-mediated toxicity","volume":"6","author":"Naisbitt","year":"1996","journal-title":"Bioorg Med Chem Let"},{"key":"10.1016\/j.jaci.2010.11.048_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","article-title":"Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity","volume":"19","author":"Cribb","year":"1991","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jaci.2010.11.048_bib25","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/mol.62.5.1011","article-title":"Haptenation of sulfonamide reactive metabolites to cellular proteins","volume":"62","author":"Manchanda","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaci.2010.11.048_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2010.11.048_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1021\/tx900034r","article-title":"Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation","volume":"22","author":"Callan","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaci.2010.11.048_bib28","doi-asserted-by":"crossref","first-page":"6647","DOI":"10.4049\/jimmunol.164.12.6647","article-title":"Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals","volume":"164","author":"Schnyder","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib29","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","article-title":"Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells","volume":"132","author":"Burkhart","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaci.2010.11.048_bib30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jaci.2009.10.031","article-title":"Stimulation of T-cells with sulfonamides and sulfonamide metabolites","volume":"125","author":"Castrejon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1124\/jpet.109.155374","article-title":"\u201cDanger\u201d conditions increase sulfamethoxazole-protein adduct formation in human antigen-presenting cells","volume":"331","author":"Lavergne","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaci.2010.11.048_bib33","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2174\/092986708785747535","article-title":"Expression and function of cytochrome p450-dependent enzymes in human skin cells","volume":"15","author":"Baron","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jaci.2010.11.048_bib34","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.jid.5700638","article-title":"A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites","volume":"127","author":"Bergstrom","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2010.11.048_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000257261","article-title":"Expression and induction of cytochrome p450 isoenzymes in human skin equivalents","volume":"23","author":"Neis","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.jaci.2010.11.048_bib36","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1351\/pac199870051129","article-title":"Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)","volume":"70","author":"Wermuth","year":"1998","journal-title":"Pure Appl Chem"},{"key":"10.1016\/j.jaci.2010.11.048_bib37","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tox.2004.12.014","article-title":"Direct T-cell stimulations by drugs\u2014bypassing the innate immune system","volume":"209","author":"Pichler","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.jaci.2010.11.048_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2332\/allergolint.55.17","article-title":"Pharmacological interaction of drugs with immune receptors: the p-i concept","volume":"55","author":"Pichler","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2010.11.048_bib40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2007.06.017","article-title":"HLA-B\u22171502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome","volume":"120","author":"Yang","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B\u22175701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2010.11.048_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2010.11.048_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B\u22175701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2010.11.048_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B\u22171502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaci.2010.11.048_bib45","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","article-title":"Strong association between HLA-B\u22175801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population","volume":"19","author":"Tassaneeyakul","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaci.2010.11.048_bib46","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","article-title":"Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis","volume":"8","author":"Kindmark","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaci.2010.11.048_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2010.11.048_bib48","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1046\/j.1365-2222.2002.01513.x","article-title":"Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides","volume":"32","author":"Burkhart","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2010.11.048_bib49","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/13.7.877","article-title":"Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones","volume":"13","author":"von Greyerz","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mcna.2010.04.003","article-title":"Drug hypersensitivity reactions: pathomechanism and clinical symptoms","volume":"94","author":"Pichler","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaci.2010.11.048_bib51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1398-9995.2009.02307.x","article-title":"CD8+ T cells mediate skin allergy to amoxicillin in a mouse model","volume":"65","author":"Rozieres","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2010.11.048_bib52","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2010.11.048_bib53","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"issue":"suppl\u00a07","key":"10.1016\/j.jaci.2010.11.048_bib54","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1093\/clinids\/13.Supplement_7.S608","article-title":"Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses","volume":"13","author":"Koch","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaci.2010.11.048_bib55","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1378\/chest.106.4.1124","article-title":"Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis","volume":"106","author":"Pleasants","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2010.11.048_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2005.10.030","article-title":"Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions","volume":"117","author":"Beeler","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2010.11.048_bib57","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910019457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674910019457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:26:19Z","timestamp":1758788779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674910019457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0091674910019457"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2010.11.048","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune pathomechanism of drug hypersensitivity reactions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2010.11.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}